Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
MOREPENLAB •NSE
Morepen Laboratories
₹88.42-0.02 (0.02%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
86.26
Today’s high
89.49
52 week low
33.05
52 week high
92.50
Open price
88.06
Previous close
88.44
Live volume
1,06,62,238
Lower circuit
70.74
Upper circuit
106.10
Fundamentals
Market Cap
₹4,846Cr
ROE
5.96%
P/E Ratio(TTM)
34.41
EPS(TTM)
2.57
P/B Ratio
3.89
Dividend Yield
0.23%
Industry P/E
37.30
Book Value
22.75
Debt to Equity
0.17
Face Value
2
Financial performance
JUN '26
Revenue (Cr)
₹575
+16.65%
Profit (Cr)
₹56.35
+258.92%
0150300450600
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +34% |
| 3Y CAGR | +6% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +394% |
| 3Y CAGR | +5% |
About
For four decades, Morepen has been a symbol of excellence and innovation in the healthcare industry. On the completion of 4 glorious decades, the company upholds Excellence as its core value. Its vast array of products have been catering to the needs of over 100 million discerning consumers.;
CEO/MD
Mr. Sushil Suri
Founded in
1984
NSE symbol
MOREPENLAB
Shareholding pattern
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,919.50 +120.20 (2.50%) | 22,495.76 | 30.6 | 5.35 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,571.00 +41.30 (1.63%) | 19,542.61 | 28.82 | 5.45 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,500.50 -144.50 (1.89%) | 18,770.50 | 110.66 | 21.51 | ||
Natco PharmaNATCOPHARM | ₹886.85 -11.50 (1.28%) | 15,887.94 | 13.88 | 1.72 |
Livesquawk •
Morepen Laboratories' Q1 revenue rises to ₹5.7B from ₹4.2B YoY.
Revenue growth reflects a 36% year-over-year increase.
Livesquawk •
Morepen Laboratories to review Q1 earnings on Aug 4.
Earnings review may act as a catalyst for investors.
2026
18SepDividendUpcomingEx date₹0.20per share
18
Sep
Dividend
Upcoming
Ex date
₹0.20
per share
For each share you hold, you will receive ₹0.20
Dividend amount₹0.20 per share
Dividend TypeFinal
Ex Date18 Sep ‘26
Record Date19 Sep ‘26
Announcement date26 May ‘26
4
Aug
Quarterly Result
Release date
26MayDividendAnnounced₹0.20per share
26
May
Dividend
Announced
₹0.20
per share
For each share you hold, you will receive ₹0.20
Dividend amount₹0.20 per share
Dividend TypeFinal
Ex Date18 Sep ‘26
Record Date19 Sep ‘26
Announcement date26 May ‘26
26
May
Quarterly & Annual Result
Release date
22
May
Quarterly & Annual Result
Release date
10
Feb
Quarterly Result
Release date
2025
14
Nov
Quarterly Result
Release date
29AugDividendEx date₹0.20per share
29
Aug
Dividend
Ex date
₹0.20
per share
For each share you hold, you will receive ₹0.20
Dividend amount₹0.20 per share
Dividend TypeFinal
Ex Date29 Aug ‘25
Record Date30 Aug ‘25
Announcement date12 May ‘25
6
Aug
Quarterly Result
Release date
12MayDividendAnnounced₹0.20per share
12
May
Dividend
Announced
₹0.20
per share
For each share you hold, you will receive ₹0.20
Dividend amount₹0.20 per share
Dividend TypeFinal
Ex Date29 Aug ‘25
Record Date30 Aug ‘25
Announcement date12 May ‘25
Events calendar
View upcoming events in other stocks